EMFLAZA® (deflazacort) is NOW indicated for the treatment of Duchenne muscular dystrophy in patients 2 YEARS OF AGE AND OLDER.


Understanding the cost of treatment can be confusing and can vary depending on your patient’s insurance. PTC Cares™ offers financial assistance programs that may be able to offer financial support to patients who qualify.

Copay Assistance Program*†

If patients with commercial insurance have out-of-pocket costs associated with EMFLAZA® (deflazacort) and qualify for assistance, PTC Cares will offer a copay assistance program.

Charitable Foundation Referrals*

If patients need additional assistance or are recipients of state or federal insurance and qualify for assistance, PTC Cares will direct them to independent charitable patient assistance foundations that may be able to help with out-of-pocket costs, as determined by the independent charitable foundations.

Patient Assistance Program*

For patients with no insurance coverage, PTC Cares may be able to provide free drug for those who qualify.

Bridge Program*

If the insurance decision is delayed, PTC Cares may offer the Bridge Program to minimize gaps in therapy.

*Low to no out-of-pocket costs for most patients who qualify

†Not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid or Medicare (including Medicare Part D)

Icon of prescription

Understanding The Prescription Process

Once you and your patient have decided on EMFLAZA, learn about what your patients can expect from the PTC Cares prescription process.

Icon of book

Arm Yourself with Resources

There are resources available for your practice as well as materials available to help educate your patients about EMFLAZA.